Loading insider details...
Latest Form 4 (Nov 4, 2026): Grant/Award of 652,063 LENZ shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 652,063 | n/a |
| Mar 30, 2026 | LENZ Therapeutics, Inc. (LENZ) | Purchase | 7,500 | $64.3K |
| Jan 6, 2026 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 84,200 | n/a |
| Nov 8, 2025 | LENZ Therapeutics, Inc. (LENZ) | Purchase | 20 | $454.20 |
| Jan 13, 2025 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 70,444 | n/a |
| May 15, 2024 | LENZ Therapeutics, Inc. (LENZ) | Purchase | 3,188 | $50.0K |
| Mar 26, 2024 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 200,000 | n/a |
| Mar 13, 2024 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 200,000 | n/a |
| Feb 27, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 6,889 | n/a |
| Nov 28, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 6,889 | n/a |